Related Experiment Video
Updated: Jul 31, 2026

11:59
Competitive Genomic Screens of Barcoded Yeast Libraries
Published on: August 11, 2011
18.4K
Genomic Variation-Mediating Fluconazole Resistance in Yeast
Wen-Yao Wang1, Hong-Qing Cai1, Si-Yuan Qu1
1Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
Biomolecules
|June 24, 2022
Summary
Genomic variations in fungi like Candida can lead to antifungal drug resistance. Understanding these genetic changes is key to overcoming treatment challenges and combating fungal infections.
Area of Science:
- Microbiology
- Genetics
- Drug Resistance
Background:
- Fungal infections represent a significant and increasing global health concern.
- Antifungal drugs are crucial for treating these infections by eliminating pathogenic fungi.
- Fungi can develop resistance to antifungal medications through genomic alterations.
Purpose of the Study:
- To review the mechanisms by which genomic variations mediate fluconazole resistance in Candida yeast.
- To elucidate the functional consequences of these genomic variations on antifungal drug efficacy.
Main Methods:
- Literature review of studies investigating genomic variations and antifungal resistance in Candida.
- Analysis of reported mutation types, including aneuploidy and loss of heterozygosity.
- Examination of how these variations impact drug-target interactions and pathways.
Main Results:
- Genomic variations such as mutation, aneuploidy, and loss of heterozygosity are key drivers of fluconazole resistance in Candida.
- These variations can alter drug targets or inhibit drug action pathways, reducing treatment effectiveness.
- Specific examples of genomic alterations and their functional impact on resistance are discussed.
Conclusions:
- Genomic variation is a critical factor in the development of antifungal resistance.
- Understanding these genetic mechanisms is essential for developing strategies to combat drug-resistant fungal infections.
- Further research into the functional genomics of antifungal resistance is warranted.

